|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plenary Sessions |
 |
|
Translational Symposia |
 |
|
Meet the Professor |
 |
|
|
|
|
|
|
|
|
|
|
Clinical Symposia |
 |
|
Corporate Symposia |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thursday, April 15 - Adipobiology |
|
|
|
|
|
|
|
|
|
15:00-15:10 |
|
|
|
|
|
|
Hirofumi Makino |
Symposium Chair, Japan |
|
|
|
|
|
|
|
|
|
|
Eberhard Ritz |
Symposium Co-Chair, Germany |
|
|
|
|
|
|
|
|
15:10-16:20 |
|
|
|
|
Chairs |
|
|
|
|
|
|
Bernardo Rodríguez-Iturbe |
|
|
|
|
|
|
Venezuela |
|
|
|
|
|
Hirofumi Makino |
Japan |
|
|
|
Speakers |
|
|
|
|
|
1. |
Sudden death in Endstage Kidney Disease |
|
|
|
|
|
Eberhard Ritz |
Germany |
|
|
|
|
2. |
Role of Adiponectin and Adiponectin Receptors in Metabolic Syndrome and Vascular Complications |
|
|
|
|
|
Takashi Kadowaki |
Japan |
|
|
|
|
|
|
|
|
16:20-18:00 |
|
|
|
|
Chairs |
|
|
|
|
|
|
Agnes B. Fogo |
USA |
|
|
|
|
|
Tsuyoshi Watanabe |
Japan |
|
|
|
Speakers |
|
|
|
|
|
1. |
Lipids, adipokines and CV mortality in ESRD patients |
|
|
|
|
Christoph Wanner |
Germany |
|
|
|
|
2. |
Body fat and survival in CKD |
|
|
|
|
|
Tetsuo Shoji |
Japan |
|
|
|
|
3. |
Adipocyte as a culprit of reno-cardiovascular injury |
|
|
|
|
Hunjoo Ha |
Korea |
|
|
|
|
4. |
Caloric imbalance and the kidney |
|
|
|
|
|
Kumar Sharma |
USA |
|
|
|
|
|
|
|
|
18:00- |
|
|
|
|
|
|
|
|
|
|
PAGE TOP |
|
|
|
|
|
Friday, April 16 - Vascular Calcification |
|
|
|
|
|
|
|
|
|
8:00-9:00 |
| Meet the Professor Breakfast |
|
|
|
|
Round-table style discussion |
|
|
|
|
|
|
|
|
9:30-10:10 |
|
|
|
|
Chair |
|
|
|
|
|
|
Hermann G. Haller |
Germany |
|
|
|
Speaker |
|
|
|
|
|
|
Recent advances in understanding interplays among the kidney, bone and vascular system |
|
|
|
|
|
Tilman Drüeke |
France |
|
|
|
|
|
|
|
|
10:10-11:25 |
| Calcification and Phosphate Biology |
|
|
|
|
Chairs |
|
|
|
|
|
|
Adeera Levin |
Canada |
|
|
|
|
|
Vuddhidej Ophascharoensuk |
|
|
|
|
|
|
Thailand |
|
|
|
Speakers |
|
|
|
|
|
1. |
Molecular mechanisms of vascular calcification: possible involvement of FGF23 |
|
|
|
|
|
Takashi Shimada |
Japan |
|
|
|
|
2. |
New insights into the pathogenesis of uremic vascular calcifications |
|
|
|
|
Jürgen Floege |
Germany |
|
|
|
|
3. |
Vascular calcification, aging, and beyond |
|
|
|
|
|
Makoto Kuro-o |
USA |
|
|
|
|
|
|
|
|
11:30-12:25 |
| Vitamin D (sponsored by CHUGAI PHARMACEUTICAL CO., LTD.) |
|
|
|
|
| Chairs |
|
 |
|
Ravi Thadhani |
USA |
|
Masafumi Fukagawa |
Japan |
|
|
|
|
Speakers |
|
|
|
|
|
1. |
Nutritional Vitamin D vs. Active Vitamin D: Which is needed in CKD patients? |
|
|
|
|
|
Kamyar Kalantar-Zadeh |
USA |
|
|
|
|
2. |
Renoprotective and Cardioprotective Effects of Vitamin D |
|
|
|
|
|
Takayuki Hamano |
USA |
|
|
|
|
|
|
|
|
|
Metabolic Syndrome
(sponsored by Nippon Boehringer Ingelheim Co., Ltd. / Astellas Pharma Inc.) |
|
|
|
|
| Chairs |
|
 |
|
Yasuhiko Tomino |
Japan |
|
Suhnggwon Kim |
Korea |
|
|
|
|
|
|
|
|
Speakers |
|
|
|
|
|
1. |
Novel components of the renin-angiotensin system (RAS): relevance to diabetic nephropathy. |
|
|
|
|
|
Mark Cooper |
Australia |
|
|
|
|
2. |
Next Generation Angiotensin Receptor Blockers: New Opportunities for Preventing Vascular Injury and Renal Damage |
|
|
|
|
|
Theodore Kurtz |
USA |
|
|
|
|
|
|
|
|
12:30-14:00 |
|
|
|
|
|
|
|
|
|
14:00-15:40 |
|
|
|
|
Chairs |
|
|
|
|
|
|
Tilman Drüeke |
France |
|
|
|
|
|
Hai Yan Wang |
China |
|
|
|
Speakers |
|
|
|
|
|
1. |
Communication and interactions between blood vessels and bone |
|
|
|
|
|
Grahame J. Elder |
Australia |
|
|
|
|
2. |
Strategies to prevent or reverse the progression of vascular calcifi cation in chronic kidney disease (CKD) |
|
|
|
|
|
Ziad A. Massy |
France |
|
|
|
|
3. |
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis |
|
|
|
|
|
Myles Wolf |
USA |
|
|
|
|
4. |
Vitamin D, endothelial dysfunction and arterial stiffness in patients with chronic kidney disease |
|
|
|
|
|
Gérard M. London |
France |
|
|
|
|
|
|
|
|
15:40-16:00 |
Coffee Break |
|
|
|
|
|
|
|
|
|
16:00-17:40 |
| Recent Diagnostic and Therapeutic Advances |
|
|
|
|
Chairs |
|
|
|
|
|
|
Carmine Zoccali |
Italy |
|
|
|
|
|
Hiroshi Itoh |
Japan |
|
|
|
Speakers |
|
|
|
|
|
1. |
The Role of Heme Oxygenase-1 in Arteriovenous Fistula Function in Hemodialysis Patients:
Prognostic Association with Length Polymorphism and Regulatory Mechanism for Far Infrared
therapy |
|
|
|
|
|
Chih-Ching Lin |
Taiwan |
|
|
|
|
2. |
Whole-body magnetic resonance angiography and its relation to biomarkers: Evidence for FGF23 as a cardiovascular risk factor? |
|
|
|
|
Tobias Larsson |
Sweden |
|
|
|
|
3. |
Effectiveness of hemodialysis access with an autologous tissue-engineered vascular graft |
|
|
|
|
|
Todd N. McAllister |
USA |
|
|
|
|
4. |
ASTRAL: a very large RCT of angioplasty and stenting for atheromatous renovascular disease (ARVD) |
|
|
|
|
|
Philip Kalra |
UK |
|
|
|
|
|
Replaced by: |
|
|
|
|
|
Targets for vascular damage: Insights from Mendelian disorders and genome-wide association studies |
|
|
|
|
|
Olivier Devuyst |
Belgium |
|
|
|
|
|
|
|
|
17:45-18:40 |
| Cardiotonic Substance (sponsored by Bayer Yakuhin, Ltd.) |
|
|
|
|
| Chairs |
|
 |
|
Sei Sasaki |
Japan |
|
Gérard M. London |
France |
|
|
|
|
Speakers |
|
|
|
|
|
1. |
Endogenous cardiotonic steroids, salt-sensitivity of blood pressure, and chronic renal failure |
|
|
|
|
|
Alexei Y. Bagrov |
USA |
|
|
|
|
2. |
Aldosterone and endotherial pathophysiology |
|
|
|
|
|
Hans Oberleithner |
Germany |
|
|
|
|
3. |
Therapeutic impact on glomerular capillary failure: an integrative biology perspective |
|
|
|
|
|
Matthias Kretzler |
USA |
|
|
|
|
|
|
|
|
|
PAGE TOP |
|
|
|
|
|
Saturday, April 17 - Oxygen Biology and Cardio-Renal Connection |
|
|
|
|
|
|
|
|
|
8:00-9:00 |
| Meet the Professor Breakfast |
|
|
|
|
Round-table style discussion |
|
|
|
|
|
|
|
|
9:30-10:10 |
|
|
|
|
Chair |
|
|
|
|
|
|
Eberhard Ritz |
Germany |
|
|
|
Speaker |
|
|
|
|
|
|
REGENERATION THERAPY FOR HEART FAILURE |
|
|
|
|
|
Issei Komuro |
Japan |
|
|
|
|
|
|
|
|
10:10-11:50 |
| Oxygen biology - Hypoxia and Oxidative stress |
|
|
|
|
Chairs |
|
|
|
|
|
|
Jürgen Floege |
Germany |
|
|
|
|
|
Ton Rabelink |
Netherland |
|
|
|
Speakers |
|
|
|
|
|
1. |
Identification of novel targets of hypoxia-responsive pathways |
|
|
|
|
|
Masaomi Nangaku |
Japan |
|
|
|
|
2. |
The ying yang of hypoxia-inducible gene expression |
|
|
|
|
|
Kai-Uwe Eckardt |
Germany |
|
|
|
|
3. |
Oxidative stress: A new perspective for an old paradigm |
|
|
|
|
|
Toshio Miyata |
Japan |
|
|
|
|
4. |
Role of oxidative stress and inflammation in the progression of CKD |
|
|
|
|
|
Bernardo Rodríguez-Iturbe |
|
|
|
|
|
|
Venezuela |
|
|
|
|
|
|
|
|
12:00-12:55 |
| Cardio-Renal Connection (sponsored by Novartis Pharma K.K.) |
|
|
|
|
| Chairs |
|
 |
|
Bernardo Rodríguez-Iturbe |
|
|
Venezuela |
|
Genjiro Kimura |
Japan |
|
|
|
|
|
Speakers |
|
|
|
|
|
1. |
Sodium as a culprit for cardio-renal syndrome |
|
|
|
|
|
Akira Nishiyama |
Japan |
|
|
|
|
2. |
Strain vessel: New hypothesis for the cardio-renal syndrome |
|
|
|
|
|
Sadayoshi Ito |
Japan |
|
|
|
|
|
|
|
|
|
| Renoprotection (sponsored by Daiichi-Sankyo) |
|
|
|
|
| Chairs |
|
 |
|
Herman G. Haller |
Germany |
|
Kimio Tomita |
Japan |
|
|
|
|
Speakers |
|
|
|
|
|
1. |
ARB, endothelial function, and renoprotection |
|
|
|
|
|
Danilo Fliser |
Germany |
|
|
|
|
2. |
New horizon of RAS inhibition in therapy for type 2 diabetic nephropathy |
|
|
|
|
Enyu Imai |
Japan |
|
|
|
|
|
|
|
|
13:00-14:00 |
|
|
|
|
|
|
|
|
|
14:00-15:40 |
|
|
|
|
Chairs |
|
|
|
|
|
|
Mark Cooper |
Australia |
|
|
|
|
|
Alan S. Go |
USA |
|
|
|
Speakers |
|
|
|
|
|
1. |
Endotoxemia, inflammation and cardiovascular disease in CKD patients |
|
|
|
|
Philip K.T. LI |
Hong-Kong |
|
|
|
|
2. |
Reducing Albuminuria for Renal and Cardiovascular Protection |
|
|
|
|
|
Fan-fan Hou |
China |
|
|
|
|
3. |
LVH and myocardiopathy in CKD |
|
|
|
|
Carmine Zoccali |
Italy |
|
|
|
|
4. |
CKD, Diabetes and CVD: Implications for populations and clinical care |
|
|
|
|
|
Adeera Levin |
Canada |
|
|
|
|
|
|
|
|
15:40-16:10 |
Coffee Break |
|
|
|
|
|
|
|
|
|
16:10-17:50 |
| Promising Target Molecules for Future Therapy |
|
|
|
|
Chairs |
|
|
|
|
|
|
Charles van Ypersele de Strihou |
|
|
|
|
|
|
Belgium |
|
|
|
|
|
Chih-Wei Yang |
Taiwan |
|
|
|
Speakers |
|
|
|
|
|
1. |
Targets for vascular damage: Insights from Mendelian disorders and genome-wide association studies |
|
|
|
|
|
Olivier Devuyst |
Belgium |
|
|
|
|
|
Replaced by: |
|
|
|
|
|
Infection and Chronic Kidney Disease - Role of Toll-like Receptor and Lessons from Leptospirosis |
|
|
|
|
|
Chih-Wei Yang |
Taiwan |
|
|
|
|
2. |
PAI-1 Antagonists: The Promise and the Peril |
|
|
|
|
|
Mesut Eren |
USA |
|
|
|
|
3. |
Is ADMA a modifiable risk factor in cardiovascular and renal diseases? |
|
|
|
|
|
James Leiper |
UK |
|
|
|
|
4. |
Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome |
|
|
|
|
|
Toshiro Fujita |
Japan |
|
|
|
|
|
|
|
|
17:55-18:50 |
| Anemia (sponsored by Kyowa Hakko Kirin Co., Ltd.) |
|
|
|
|
| Chairs |
|
 |
|
Tadao Akizawa |
Japan |
|
Kai-Uwe Eckardt |
Germany |
|
|
|
|
Speakers |
|
|
|
|
|
1. |
Chronic Kidney Disease Japan Cohort (CKD-JAC) Study |
|
|
|
|
|
Seiichi Matsuo |
Japan |
|
|
|
|
2. |
Latest perspectives on outcomes of ESA therapy in CKD |
|
|
|
|
|
Robert Toto |
USA |
|
|
|
|
|
|
|
|
|
PAGE TOP |
|
|
|
|
|
Sunday, April 18 - Vascular Senescence |
|
|
|
|
|
|
|
|
|
8:30-9:10 |
|
|
|
|
Chair |
|
|
|
|
|
|
Kumar Sharma |
USA |
|
|
|
Speaker |
|
|
|
|
|
|
Impact of kidney function on atherothrombotic complications in the general population and in patients with heart disease |
|
|
|
|
Alan Go |
USA |
|
|
|
|
|
|
|
|
9:10-10:25 |
| Vascular Injury and Regeneration |
|
|
|
|
Chairs |
|
|
|
|
|
|
Kosaku Nitta |
Japan |
|
|
|
|
|
Oliver Devuyst |
Belgium |
|
|
|
Speakers |
|
|
|
|
|
1. |
Renal Dysfunction Disrupts Macrophage Lipid Homeostasis and Infl ammation |
|
|
|
|
|
Valentina Kon |
USA |
|
|
|
|
2. |
PPARγ and Chronic Kidney Disease |
|
|
|
|
|
Agnes B. Fogo |
USA |
|
|
|
|
3. |
Microvascular remodeling and progression of renal failure |
|
|
|
|
|
Ton Rabelink |
Netherland |
|
|
|
|
|
|
|
|
10:25-11:40 |
| Vascular Ageing and Senescence |
|
|
|
|
Chairs |
|
|
|
|
|
|
Danilo Fliser |
Germany |
|
|
|
|
|
Naoki Kashihara |
Japan |
|
|
|
Speakers |
|
|
|
|
|
1. |
Advanced glycation (AGEs) and cardio-renal ageing |
|
|
|
|
|
Josephine M. Forbes |
Australia |
|
|
|
|
2. |
Disruption of the Angiotensin II type 1 receptor promotes longevity in mice |
|
|
|
|
|
Ariela Benigni |
Italy |
|
|
|
|
3. |
Premature Vascular Senescence: the decline and fall of blood vessels |
|
|
|
|
|
Michael Goligorsky |
USA |
|
|
|
|
|
|
|
|
11:40 |
|
|
|
|
|
|
Tadao Akizawa |
Symposium Co-Chair, Japan |
|
|
|
|
|
|
|
|
|
PAGE TOP |
|
|
|
|
